Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology ; day:12 ; month:7 ; year:2018 ; pages:1-13
Molecular neurobiology ; (12.7.2018), 1-13
- Creator
-
Schemmert, Sarah
- Contributor
-
Schartmann, Elena
Zafiu, Christian
Kass, Bettina
Hartwig, Sonja
Lehr, Stefan
Bannach, Oliver
Langen, Karl-Josef
Shah, Nadim Joni
Kutzsche, Janine
Willuweit, Antje
Willbold, Dieter
SpringerLink (Online service)
- DOI
-
10.1007/s12035-018-1209-3
- URN
-
urn:nbn:de:101:1-2018092023345128106587
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schemmert, Sarah
- Schartmann, Elena
- Zafiu, Christian
- Kass, Bettina
- Hartwig, Sonja
- Lehr, Stefan
- Bannach, Oliver
- Langen, Karl-Josef
- Shah, Nadim Joni
- Kutzsche, Janine
- Willuweit, Antje
- Willbold, Dieter
- SpringerLink (Online service)
Other Objects (12)
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
In vivo Charakterisierung Amyloid-β-Oligomer eliminierender D-enantiomerer Peptide zur Therapie der Alzheimer’schen Demenz
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
In vivo Charakterisierung Amyloid-β-Oligomer eliminierender D-enantiomerer Peptide zur Therapie der Alzheimer’schen Demenz
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
In vivo Charakterisierung Amyloid-β-Oligomer eliminierender D-enantiomerer Peptide zur Therapie der Alzheimer’schen Demenz
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell